CD274 and neoplasm: Activation of the PD-1/PD-L1 signaling pathway inhibits the proliferation and activation of CD4+ T cells and CD8+ T cells, suppresses the expression of cytokines, alters the tumor microenvironment, weakens the body’s surveillance and clearance capabilities against tumor cells, and promotes tumor cells to evade immune surveillance and killing (16).